Weronika Anna Hudecka

Ms. Weronika Anna Hudecka


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Małgorzata Katarzyna KowalskaMałgorzata Katarzyna Kowalska
Małgorzata Katarzyna Kowalska
AEAhmed El-Mallul El-Mallul
Ahmed El-Mallul El-Mallul
WHWeronika Anna Hudecka
Weronika Anna Hudecka
JMJoanna Elżbieta Majewska
Joanna Elżbieta Majewska
PLPiotr Jan Lubojański
Piotr Jan Lubojański
ŁBŁukasz Michal Bednarczyk
Łukasz Michal Bednarczyk
The aim of this article is to present the current state of knowledge regarding the use of GLP-1 agonists in the treatment of type 2 diabetes, obesity, and other potential clinical indications, including neurodegenerative conditions. The article describes the characteristics of the diseases discussed, with particular emphasis on the pathophysiological mechanisms and the impact of metabolic disorders on the course of the diseases. In addition, the specific role of GLP-1 receptor agonists and their mechanisms of action leading to improved clinical outcomes were discussed, including their impact on molecular pathways involved in glucose metabolism regulation, inflammatory processes, carcinogenesis, and neuroprotection. Based on meta-analyses of available clinical trials, the evidence supporting the effectiveness of GLP-1 agonist therapy in glycemic control, weight loss, and improvement of metabolic parameters was synthesized. Additionally, potential benefits beyond the metabolic system are discussed, including neuroprotective effects and impact on patients’ cardiovascular profiles, as well as risks and adverse effects associated with the use of GLP-1 agonists. The collected data indicate the growing role of GLP-1 agonists as an innovative and effective therapeutic strategy, while emphasizing the need for further research in the context of new clinical indications.

Verified
Journal Article
Open access
PDF file
Małgorzata Katarzyna KowalskaMałgorzata Katarzyna Kowalska
Małgorzata Katarzyna Kowalska
AEAhmed El-Mallul El-Mallul
Ahmed El-Mallul El-Mallul
JMJoanna Elżbieta Majewska
Joanna Elżbieta Majewska
WHWeronika Anna Hudecka
Weronika Anna Hudecka
SOSara Małgorzata Orłowska
Sara Małgorzata Orłowska
ŁBŁukasz Michal Bednarczyk
Łukasz Michal Bednarczyk
This review covers issues related to the characteristics, diagnosis, and treatment of colorectal cancer (CRC). It discusses traditional methods of treating colorectal cancer, including surgery, chemotherapy, and radiotherapy, as well as modern approaches, including targeted therapies, immunotherapy, and innovative gene therapy strategies. Particular attention is paid to the identification of molecular subtypes of CRC, which has revolutionized treatment in advanced stages of the disease and contributed to improved patient survival. The role of biomarkers, including liquid biopsy, in diagnosis, therapy monitoring, and treatment response assessment is emphasized. The potential of artificial intelligence in planning and optimizing surgical procedures is also discussed, opening up new possibilities in personalized therapy. This article provides up-to-date knowledge on the molecular mechanisms of CRC, diagnostic prospects, and directions for the development of precision therapies, serving as a valuable source of information for both clinicians involved in the treatment of CRC and patients wishing to deepen their knowledge of the disease and modern therapeutic options.

17 June 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Małgorzata Katarzyna KowalskaMałgorzata Katarzyna Kowalska
Małgorzata Katarzyna Kowalska
SOSara Małgorzata Orłowska
Sara Małgorzata Orłowska
ŁBŁukasz Michal Bednarczyk
Łukasz Michal Bednarczyk
JMJoanna Elżbieta Majewska
Joanna Elżbieta Majewska
WHWeronika Anna Hudecka
Weronika Anna Hudecka
Psoriasis is a chronic inflammatory skin disease with a complex clinical picture that remains incurable and requires ongoing dermatological care. The purpose of this literature review is to identify the latest therapeutic strategies used to treat psoriasis, taking into account both the efficacy of modern approaches and their impact on patients’ quality of life. The cornerstone of psoriasis treatment remains regular skin care through the use of emollients, which support the effectiveness of other topical therapies used such as corticosteroids. In addition, the review presents current epidemiological data on the prevalence of psoriasis worldwide, with a focus on European countries and Poland. The article discusses innovative approaches in therapy, including targeted biologics, modern forms of topical therapy, and the role of emollients in comprehensive skin care, as well as various cosmetological treatments aimed at removing the excessively accumulated stratum corneum, and improving the degree of hydration of psoriatic skin. The review also included current expert recommendations and guidelines from scientific societies that guide the treatment and care of psoriatic skin. The results of the analyses underscore the need for targeted therapies and the importance of a holistic approach to patient care. As the collected data indicate, the possibilities for effective topical and systemic treatment of psoriasis are increasing all the time due to research into newer and newer active substances that are expected to improve the efficacy of treatment, the comfort of life for psoriasis patients and reduce the side effects of long-term therapy.

10 August 2026 in Sustainability
Verified
Journal Article
Open access
PDF file
Małgorzata Katarzyna KowalskaMałgorzata Katarzyna Kowalska
Małgorzata Katarzyna Kowalska
JGJosé Luis Guil-Guerrero
José Luis Guil-Guerrero
ŁBŁukasz Michal Bednarczyk
Łukasz Michal Bednarczyk
PLPiotr Jan Lubojański
Piotr Jan Lubojański
SOSara Małgorzata Orłowska
Sara Małgorzata Orłowska
WHWeronika Anna Hudecka
Weronika Anna Hudecka
For decades, industrial trans fatty acids (iTFAs) have remained a critical focus of the scientific community, the food industry, and regulatory authorities because of their well-established role in the development of cardiovascular diseases, metabolic disorders, and chronic systemic inflammation. Rather than providing a descriptive overview, this review critically synthesizes current evidence on the elimination of industrial TFAs by integrating health, technological, regulatory, and sustainability perspectives into a comprehensive interdisciplinary analysis. The review outlines the biochemical characteristics and dietary sources of trans fatty acid isomers, highlighting the continuing scientific debate regarding the differential health effects of industrially produced and naturally occurring ruminant-derived TFAs. It also examines the evolution of scientific evidence that led to major regulatory actions by international organizations, including the World Health Organization (WHO) and the European Commission, resulting in legally binding restrictions that have substantially reduced industrial TFA intake and improved public health. Particular emphasis is placed on the critical assessment of current fat reformulation strategies, considering not only their technological functionality but also their nutritional quality, long-term metabolic implications, and contribution to sustainable food systems. Full hydrogenation, fractionation, chemical and enzymatic interesterification, and oleogelation are comparatively evaluated with respect to their advantages, limitations, and potential technological, nutritional, and environmental trade-offs. In addition, lipid microencapsulation is discussed as an emerging strategy for protecting oxidation-sensitive polyunsaturated fatty acids (PUFAs), thereby facilitating their incorporation into functional foods while maintaining nutritional quality. Unlike previous reviews that primarily focus on health outcomes or individual processing technologies, this review systematically integrates the sustainability dimensions of alternative fat modification approaches, including resource efficiency, energy consumption, clean label product development, and circular economy principles. Furthermore, it identifies current knowledge gaps related to the long-term metabolic safety, industrial scalability, and environmental performance of emerging lipid technologies. By combining these complementary perspectives, the review provides a comprehensive interdisciplinary synthesis that supports evidence-based fat reformulation and offers practical guidance for researchers, food manufacturers, and policy makers seeking to develop safer, nutritionally improved, technologically functional, and environmentally sustainable lipid systems.